This inventor holds 1 USPTO granted patent. Top assignee: Daiichi Pharmaceutical Co., Ltd.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: David O'Gorman: Innovator in Therapeutic Agents for Amnesia
Introduction
David O'Gorman is a notable inventor based in Dublin, Ireland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of therapeutic agents. His work focuses on addressing cognitive impairments, specifically amnesia.
Latest Patents
David O'Gorman holds a patent for a prophylactic or therapeutic agent for amnesia. This medicament comprises an active ingredient represented by the formula: R—CH,CONH—R, where R represents a pyridyl group, a substituted pyridyl group, a phenyl group, or a substituted phenyl group. The other component, R, represents a 2-oxo-1-pyrrolidinyl group, which may be substituted. This invention is particularly useful for the preventive and therapeutic treatment of amnesia caused by anesthetic agents, such as propofol.
Career Highlights
Throughout his career, David O'Gorman has been associated with Daiichi Pharmaceutical Co., Ltd., where he has contributed to various research initiatives. His innovative approach to medicinal chemistry has garnered attention in the pharmaceutical industry.
Collaborations
David has collaborated with esteemed colleagues, including Ciaran M Regan and Alan O'Connell. These partnerships have enhanced the research and development efforts within his field.
Conclusion
David O'Gorman's work in developing therapeutic agents for amnesia showcases his commitment to advancing medical science. His innovative contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile